MedTrace Logo

A Registry Study of Biomarkers in Mitral Valve Disease (BIOMS-MVD)

NCT05141292 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2022-02-04

No results posted yet for this study

Summary

The registry study aims to discover the prognostic value of bio-markers in mitral valve disease

Conditions

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jie Du · The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart,Lung and Blood Vessel Diseases

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2023-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05141292 on ClinicalTrials.gov